Comparison of the Efficacy and Safety of Different Doses of Linaclotide for Patients with Chronic Constipation: A Meta-Analysis and Bayesian Analysis

Figure 3

The forest plot of CSBM responder rate. (a) Linaclotide vs. placebo. (b) Extremely low dose of linaclotide vs. placebo. (c) Low dose of linaclotide vs. placebo. (d) Medium dose of linaclotide vs. placebo. (e) High dose of linaclotide vs. placebo.

(a)

(b)

(c)

(d)

(e)